The Cooking for Health Optimization and Disease Prevention (CHOP) Trial

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age55-120
SponsorTulane University

About this trial

Poor nutrition-related diseases disproportionately impact seniors and racial/ethnic minorities who are more likely to experience disparities in proper nutrition. Culinary medicine is a new evidence-based educational approach that blends the art of food and cooking with the science of medicine. Recently, culinary medicine is proposed by the 2020-2030 Strategic Plan for NIH Nutrition Research and national 'Food is Medicine (FIM)' Movement as potential solutions for improving healthy eating, creating social and emotional connections, and nutrition-related health equity. Built upon the well-established community teaching kitchen at The Goldring Center for Culinary Medicine (GCCM) at Tulane University and nearly 10 years of experience in delivering culinary education of Mediterranean diet (MedDiet), the investigators will conduct a randomized controlled trial (RCT) to test the feasibility and effectiveness of 3-month community teaching kitchen-based culinary education of MedDiet on improving cardiometabolic and mental health among racially and ethnically diverse seniors.

Eligibility criteria

Qualifiers

Age 55 years or older

English speaking

Ability to provide informed consent.

Disqualifiers

Medical history of cardiovascular disease (CVD) or cancer.

Food allergies including, but not limited to, milk, eggs, shellfish, nuts, wheat or gluten, and soy.

Special diets including, but not limited to, Mediterranean, veganism, vegetarianism, gluten-free, and the ketogenic diet.

Current use of medications that could affect blood glucose and lipids levels including, but not limited to, insulins (Humalog, Novolog, insulin detemir, etc.), anti-diabetic medications (metformin, sulfonylureas, meglitinides, etc.), Ozempic. HAART, and beta blockers.

Trial design

Treatments tested in this trial

  • Cooking class
  • Standard of care

Treatment groups

96 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Tulane University

Lead sponsor

Humana Foundation

Collaborator